Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Next-generation sequencing technology for medicine and research in Mainz

09.06.2010
Mainz’s Center for Translational Oncology and Immunology (TrOn) has received one of the world's first Illumina HiSeq genome sequencers

A next generation genome sequencer has been received in the newly launched Center for Translational Oncology Mainz and Immunology (TrOn) in Mainz. With the Illumina HiSeq 2000 instrument, the genetic material of cells can be completely decoded within a few days.

"The performance of TrOn as an innovation center and hub of the CI3 regional network of science and business is strengthened by this technology. This is therefore another important step to make Mainz a globally competitive center for personalized medicine," says Univ.-Prof. Dr. Ugur Sahin, director of TrOn. “The new technology allows us to examine the genetic information in tumor and immune cells quickly and inexpensively in order to gain a better understanding of the interplay of cancer treatment and immune system. This is necessary to develop customized therapies for individual patients."

"The new instrument is eight times more powerful than previous methods," says Dr. John Castle, head of Bioinformatics/Genomics at TrOn. "This represents not only a significant reduction of time and costs, but also more information that must be analyzed. For this, we are well positioned by our cooperation with the University of Mainz Center for High Performance Computing (ZDV)."

Understanding the characteristics of individual cancer patients is the basis for a customized treatment and thus critical to a successful therapy. "Individualized" and targeted medicine offers a great promise to significantly improve cancer therapy, both decreasing the cost of health care and improving patient lives. The dramatically increased ability to decode genomes ushered in by this next era of DNA sequencing makes the vision possible.

University President Univ.-Prof. Dr. Georg Krausch, a member of the successful Mainz "City of Science 2011" team, commented: "This is one of the puzzle pieces which we want at our site: cutting-edge research to resolve major social challenges."

Press contact
Christine Castle
CIMT Communications
TrOn - Translationale Onkologie gGmbH
Phone: +49 (0) 6131/17-8025
E-Mail: christine.castle@tron-mainz.de
Internet: http://www.tron-mainz.de
About the Center for Translational Oncology and Immunology (TrOn)
The Center for Translational Oncology and Immunology (TrOn) was founded in February 2010. Its partners include the state of Rhineland-Palatinate, the Johannes Gutenberg-University Mainz and the University Medical Center Mainz. The mission of the TrOn, under the direction of Univ.-Prof. Dr. Ugur Sahin, is to advance medical and scientific discoveries from research to patient treatment.
About the CI3-cluster
The cluster for Individualized Immune Intervention (CI3) is a regional network of science and industry, including three universities, six colleges, two Max Planck Institutes, the Paul-Ehrlich-Institute, the Association for Cancer Immunotherapy (CIMT), the European Business School, the Center for Translational Immunology and Oncology (TrOn), four large pharmaceutical companies and more than 180 small and medium-sized companies from biotechnology and health care. The network focuses on immunotherapy, the fastest growing pharmaceutical market segment, with the mission to turn the Rhine-Main region into a European immunotherapy center.

Caroline Bahnemann | idw
Further information:
http://www.tron-mainz.de
http://www.unimedizin-mainz.de/

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>